Patrícia Lobato Calafate Paula

Ms. Patrícia Lobato Calafate Paula

Instituto Superior Técnico, Lisbon, Lisboa, Portugal
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Sandra Godinho SilvaSandra Godinho Silva
Sandra Godinho Silva
Patrícia Lobato Calafate PaulaPatrícia Lobato Calafate Paula
Patrícia Lobato Calafate Paula
JSJosé Paulo Da Silva
José Paulo Da Silva
DMDalila Mil-Homens
Dalila Mil-Homens
Miguel C. TeixeiraMiguel C. Teixeira
Miguel C. Teixeira
Tina Keller-CostaTina Keller-Costa
Tina Keller-Costa
Two novel natural products, the polyketide cuniculene and the peptide antibiotic aquimarin, were recently discovered from the marine bacterial genus Aquimarina. However, the diversity of the secondary metabolite biosynthetic gene clusters (SM-BGCs) in Aquimarina genomes indicates a far greater biosynthetic potential. In this study, nine representative Aquimarina strains were tested for antimicrobial activity against diverse human-pathogenic and marine microorganisms and subjected to metabolomic and genomic profiling. We found an inhibitory activity of most Aquimarina strains against Candida glabrata and marine Vibrio and Alphaproteobacteria species. Aquimarina sp. Aq135 and Aquimarina muelleri crude extracts showed particularly promising antimicrobial activities, amongst others against methicillin-resistant Staphylococcus aureus. The metabolomic and functional genomic profiles of Aquimarina spp. followed similar patterns and were shaped by phylogeny. SM-BGC and metabolomics networks suggest the presence of novel polyketides and peptides, including cyclic depsipeptide-related compounds. Moreover, exploration of the ‘Sponge Microbiome Project’ dataset revealed that Aquimarina spp. possess low-abundance distributions worldwide across multiple marine biotopes. Our study emphasizes the relevance of this member of the microbial rare biosphere as a promising source of novel natural products. We predict that future metabologenomics studies of Aquimarina species will expand the spectrum of known secondary metabolites and bioactivities from marine ecosystems.